CeQur, a 3-day wearable insulin patch for injection-free dosing, closed the Series C5 financing round at $115 million. Credit Suisse Entrepreneur Capital and Endeavour Vision
Insulin Patch
Credit Suisse Entrepreneur Capital and Endeavour Vision led the financing round